Novo CEO’s First Test is Winning Back the US Weight Loss Market

Novo Nordisk’s weight loss drugs Ozempic and Wegovy transformed the firm into a global pharmaceutical giant.

But four years after Wegovy’s US launch, the Danish drugmaker’s market value has plummeted. Sanne Wass explains why

(Source: Bloomberg)


www.bloomberg.com
#Novo #CEOs #Test #Winning #Weight #Loss #Market